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Abstract
A selective trans-packaging system was developed to produce and isolate bovine viral diarrhea virus (BVDV) pseudo-particles with complementing reporter replicons and their packaging proteins expressed in trans with recombinant vaccinia virus. The encapsidation of replicon rNS3-5B was dependent not only on the in trans expression of structural proteins C, Erns, E1 and E2, but also the nonstructural proteins,
p7 and contiguous precursor NS2-3-4A. Nonstructural p7, NS4B, NS5A or NS5B could be expressed in cis and in trans with precursor NS2-34A without significantly affecting virion assembly efficiency. NS2-3-4A was identified as an in trans functional precursor in virion assembly.
BVDV genomes with mutant NS5B, which did not undergo active replication, were packaged 5-fold less efficiently than the intact genomes
demonstrating the importance of replication in virion packaging. These results suggest that genome replication and assembly are closely associated, consistent with a model in which these two steps are coupled for maximum efficiency.
Keywords: BVDV, pseudo-particles, trans-packaging, complementation, NS2-3-4A precursor, replication, virion assembly

pathic (ncp) and cytopathic (cp) biotypes that are distinguished by
their effect on cultured cells (Gillespie et al., 1960). Expression of NS3
as a separate protein is a hallmark of cp-BVDV (Donis and Dubovi,
1987). NS3 is co-linear to the C-terminal portion of NS2-3 and its expression by cp-BVDV is the result of complex genetic changes (Meyers et al., 1996). However, an almost complete cleavage of NS2-3 in
ncp-BVDV during the early hours of infection has been reported recently, indicating that temporal modulation of NS2-3 processing is
crucial for replication and pathogenicity (Lackner et al., 2004).
Genetic analyses have shown that genome replication requires
the five NS proteins, NS3, NS4A, NS4B, NS5A and NS5B, of which
only NS5A is complementable in trans (Grassmann et al., 2001;
Moser et al., 1999; Tautz et al., 1999). The known relevant catalytic
functions in this complex are the nucleotidyl transferase of NS5B
(Lai et al., 1999; Steffens et al., 1999), as well as the ATPase and RNA
helicase of NS3 (Grassmann et al., 1999). The roles of NS4A, NS4B
and NS5A in RNA replication are unknown (Qu et al., 2001). Pestivirus virions are enveloped particles between 40–60 nm in diameter. They consist of viral genomic RNA, the C protein, the envelope
glycoproteins Erns, E1, and E2, as well as the lipid membrane envelope. Electron microscopy of infected cells has suggested that particles bud into the lumen of cytoplasmic vesicular structures (Ohm-

Introduction
Bovine viral diarrhea virus (BVDV) is an economically important pathogen of domestic livestock and wild ruminants. The virus is a member of the genus Pestivirus, which together with the
Flavivirus and Hepacivirus genera constitute the family Flaviviridae
(Van Regenmortel, 1999). The genome of BVDV is approximately
12.3 kb in length and consists of a single long open reading frame
(ORF) flanked by 5′ and 3′ nontranslated regions (NTRs) (Collett et
al., 1988). Translation of the ORF is mediated by an internal ribosome entry site (IRES) (Poole et al., 1995). The ORF is translated into
a single large polyprotein which is co- and post-translationally processed into at least 11 mature structural and nonstructural (NS) viral proteins as follows: Npro-capsid (C)-Erns-E1-E2-p7-NS2-3-NS4ANS4B-NS5A-NS5B (Collett et al., 1988; Elbers et al., 1996; Tautz et al.,
1997). Npro is an autoprotease that cleaves at its own carboxyl-terminus to release the C protein (Rumenapf et al., 1998). The cleavages of
C, Erns, E1, E2 and p7 are catalyzed by host cellular signal peptidases
(Rumenapf et al., 1993, 1998). The N-terminal, one-third of NS3 encodes a serine protease that functions in concert with cofactor NS4A
to mediate processing of all downstream NS proteins (Collett et al.,
1988; Failla et al., 1994). BVDV isolates are divided into noncyto331
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ann, 1990). The mechanism by which genomic RNA is incorporated
into virions during budding remains unknown. The spatial relationships between the sites of RNA replication and virion assembly are not known and RNA packaging signals have not been identified in any of the Flaviviridae members. There is a growing body of
evidence indicating that Pestivirus NS proteins participate in the assembly of infectious virions (Agapov et al., 2004; Ansari et al., 2004).
However, it is not known how the NS proteins contribute to the assembly process. One possibility is that certain NS proteins participate in coupling the genome replication process to that of virion assembly. The results described in this study demonstrate a significant
involvement of NS proteins in genome packaging and also suggest
that genome packaging is more efficient when coupled to an active
replicase complex.
Results
Development of an efficient BVDV virion packaging assay system
We recently reported the development and use of a bicistronic
replicon derived from the cp-BVDV strain NADL that expresses
firefly luciferase to facilitate detection of its biological activity within
electroporated cells (Ansari et al., 2004; Horscroft et al., 2005; Vas-

D. L i a n g

et al. in

V i r o l o g y 387 (2009)

silev and Donis, 2000). This replicon, termed rNS3-5B, expresses
the minimal complement of NS proteins required for genome replication (Ansari et al., 2004; Behrens et al., 1998). To study the role
of NS proteins in BVDV genome packaging into virions, we constructed an additional reporter replicon, termed rp7-NS5B (Figure
1A). The upstream cistron of this replicon expresses firefly luciferase and neomycin phosphotransferase, whereas the second cistron
expresses the polyprotein encoding the complete set of NS proteins
starting from p7 to NS5B, hence rp7-NS5B is approximately 1.5 kb
longer than rNS3-5B. The expression of the second cistron is mediated by the encephalomyocarditis virus (ECMV) IRES. The RNA
transcripts derived from both replicons resulted in the expression
of increased levels of firefly luciferase following RNA electroporation into bovine cells. Luciferase activity was detected as early as
24 h post-electroporation and was maximal at 48 h (Figure 1B). Both
replicons, rNS3-5B and rp7-NS5B, expressed equivalent levels of luciferase. In contrast, cells electroporated with rNS3-5Bgdd, showed
only background levels of luciferase activity, indicating that the significant levels of luciferase activity observed after rNS3-5B or rp7NS5B were dependent on the polymerase activity of NS5B to mediate RNA amplification (Figure 1B). More importantly, luciferase
levels were found to correlate with the intracellular amounts of rep-

Figure 1. Replication and packaging of subgenomic BVDV replicons by helper virus. (A) Schematic diagram of bicistronic reporter BVDV replicons rNS3-5B and rp7-NS5B as indicated: F-luc = firefly luciferase, Ubi = ubiquitin, Neo = neomycin phosphotransferase and EMCV = internal ribosome entry site of EMCV. (B) Firefly luciferase activity from total cell lysates measured at the indicated hours post-electroporation (hpe) with
RNA transcripts of rNS3-5B (filled square), rp7-NS5B (open triangle) and rNS3-5Bgdd (diamond), respectively. All values were normalized for
electroporation efficiency by measuring the Renilla luciferase from a monocistronic RNA co-electroporated with the replicon RNA transcripts.
Data represents one of the repeated experiments. (C) Northern blotting analysis to determine replication efficiency of rNS3-5B (lane 2), rp7-NS5B
(lane 3) in NCL1 cells at the indicated hours (hrs) after electroporation with RNA transcripts. RNA derived from rNS3-5Bgdd served as a control (lane 1). Panel a shows replicon RNA in total cellular RNA extracted from 1 × 106 cells. Panel b is an image of the ethidium bromide stained
agarose gel of total cellular RNA that was blotted and probed in panel a. (D) Transduction of luciferase expression to naïve (indicator) cells using supernatant collected from cells persistently infected by ncp-BVDV-2 helper virus for 36 h before electroporation with reporter BVDV replicon
RNAs. Luciferase activities were tested 48 h post-RNA electroporation or infection with packaged/pseudotyped replicon RNAs. Packageable replicons refer to replicons recovered from source cells transfected with RNA transcripts and used for the transduction of indicator cells. Transduced
replicons refer to replicons recovered from indicator cells following inoculation with packaged replicons.
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licon RNA as indicated by northern blot hybridization (Figure 1C).
The luciferase levels from the BVDV replicons were normalized for
electroporation efficiency by quantification of a co-electroporated
RNA encoding Renilla luciferase. To this end, a fraction of the electroporated cells was cultured separately in which Renilla luciferase
activity was monitored at 4 h post-electroporation (data not shown).
An excellent correlation was observed between normalized RNA
levels as detected by northern blot analysis and normalized firefly
luciferase expression at all time points analyzed (Figs. 1B, C). However, it appeared that the kinetics of RNA accumulation was slightly
different between the two reporter replicons, with rNS3-5B RNA accumulation delayed relative to rp7-NS5B.
Previous studies have demonstrated that BVDV replicons can be
packaged by infecting with helper BVDV virus, like the naturally-occurring pestivirus defective interfering (DI) particles that they emulate (Behrens et al., 1998; Meyers and Thiel, 1995). To ascertain if the
introduction of foreign RNA elements into the BVDV subgenomic
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RNA might interfere with its encapsidation, we electroporated the
reporter replicon RNAs into helper BVDV genotype 2 (BVDV-2) infected cells and analyzed the cell culture medium harvested 2 days
after electroporation for its ability to transduce luciferase expression in bovine cells. The results revealed that both versions of reporter replicons were able to transduce luciferase expression in the
indicator cell monolayer (Figure 1D) and there were no significant
differences between the rNS3-5B and rp7-NS5B replicons in the release of virions into the culture fluids (Figure 1D). The levels of luciferase expression in the transduced cells were higher than in the
electroporated cells. These results indicated that replicons rNS3-5B
and rp7-NS5B retain the necessary cis-elements for packaging, although it is not known if BVDV structural proteins can exclude foreign RNA molecules.
A recent report indicated that encapsidation of the BVDV genome was strictly dependent on the presence of the NS2-3 protein
(Agapov et al., 2004). The finding that the two reporter replicons dif-

Figure 2. Packaging of BVDV replicons using recombinant vaccinia viruses expressing different lengths of BVDV proteins in trans. (A) Schematic
representation of recombinant vaccinia virus genome expressing different lengths of BVDV proteins. The thymidine kinase (TK) gene of vaccinia
virus WR was replaced with BVDV coding regions having truncations from the C-terminal end of the BVDV genome: T7 = T7 promoter, R = Ribozyme of hepatitis D virus. Asterisk (*) with NS5B indicates the mutation of GDD motif to ATR. (B) Western blot analysis of NCL1 cells infected
with recombinant vaccinia virus expressing different length of BVDV proteins. Total cell lysate corresponding to 2 × 104 NCL1 cells was loaded
into each lane of an 8% SDS-PAGE gel, electrophoresed, transferred to a membrane and protein detected using monoclonal antibodies against E2
(panel a) or NS3 (panel b). Lanes 1 to 5 represent NCL1 cells infected with recombinant vaccinia virus vT7-cpNgdd, vT7-ncpNgdd, vT7-ncpNS2-3,
vT7-p7 and vT7-E2, respectively. Lane 6 is normal control cells while lane 7 represents NCL1 cells persistently-infected with ncp-BVDV. (C) Transpackaging of BVDV replicons using recombinant vaccinia virus vT7-ncpNgdd. NCL1 cells were infected with wild type (WR) or vT7-ncpNgdd
vaccinia viruses after 36 h post-RNA electroporation of the two replicons. The trans-packaged replicon pseudo-particles from the cells were filtered and applied onto naive cells. Luciferase activities were tested 48 h after electroporation or infection of replicons. White bars represent replicon rNS3-5B, while gray bars represent replicon rp7-NS5B. A fraction of the supernatant was incubated with 100 serum neutralizing units of
BVDV neutralizing antibody for 30 min at room temperature prior to infection of naive NCL1 cells. Data represents one of the repeated experiments. (D) Semliki Forest virus replicons fail to be packaged by vaccinia virus vT7-ncpNADLgdd. NCL1 cells were electroporated with transcripts
derived from SFV3-lacZ. Four hours post-RNA electroporation, cells were infected with vaccinia virus vT7-ncpNADLgdd and stained for expression of β-galactosidase after 8 h (panel a). The supernatant from these cells was collected 24 h post-RNA electroporation, passed through a 0.1 mm
filter and applied to fresh NCL1 naive cells (indicator cells) and further analyzed for expression of β-galactosidase after 12 h (panel b).
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fering in the expression of NS2-3 were efficiently incorporated into
particles in the presence of helper ncp-BVDV infection prompted us
to determine the minimum complement of viral proteins required
for the incorporation of the subgenomic reporter replicon into virus
particles. To this end, we engineered a helper vaccinia virus expression system that could generate either the entire wt BVDV genomic
RNA and efficiently encode the BVDV polyprotein in infected cells
or any selected mutants of interest (e.g. deletion mutants or mutants with BVDV polyprotein having a catalytically inactive NS5B)
(Figure 2A). The engineered vaccinia viruses, vT7-NADL and vT7cpNgdd, expressed the entire polyprotein of BVDV in infected cells
(Figure 2B) and nearly 100% of the cells were positive by indirect
immunofluorescence staining using an anti-E2 monoclonal antibody
(Mab) (data not shown). Western blot analyses of vT7-cpNgdd infected cells revealed expression and correct processing of E2 and
NS3 (Figure 2B). The vT7-NADL released infectious BVDV into the
culture medium (data not shown).
To assess the efficiency of the complete set of BVDV proteins expressed by the vaccinia system in encapsidating BVDV reporter replicons into functional viral particles, we analyzed the expression
of luciferase in indicator cells inoculated with cell culture medium
from the packaging cells, the rNS3-5B or rp7-NS5B RNA electroporated cells following infection with the helper vT7-ncpNgdd recombinant vaccinia virus. The culture fluid from the packaging cells was
passed through a 0.1 μm filter to remove the vaccinia virus and the
filtered fluid inoculated onto a fresh monolayer of indicator cells
to assess transduction of luciferase expression. Luciferase activity
measured from the indicator cells revealed the delivery of the replicon rNS3-5B and rp7-NS5B to the new monolayer (Figure 2C). Delivery of the two packaged replicons have comparable efficiency. In
contrast, wild type vaccinia virus WR could not trans-package the
BVDV replicon, hence only background levels of luciferase activ-
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ity were detected (Fig 2C). Furthermore the transduction of luciferase activity to the indicator cells was blocked by pre-incubation of
the cell culture fluids with BVDV neutralizing Mabs against E2 (Figure 2C) indicating that the packaged replicon contained authentic
BVDV E2 protein on the surface. Taken together, these results demonstrate that the replicon RNAs were encapsidated and transduced
luciferase expression in the target cells. These encapsidated virions
were also able to pass through a 0.1 μm filter with which vaccinia
virus virions were effectively excluded.
BVDV virion packaging machinery is highly selective
Although the packaging of the reporter replicon by trans-complementing with recombinant BVDV-vaccinia appears to recapitulate the natural process of DI propagation, the mechanism responsible for packaging the RNA is still unknown. The efficiency of virus
assembly would be enhanced by the selectivity of the genome packaging machinery. Such selectivity should be correlated with the failure to encapsidate a non-cognate viral RNA genome that is present
in abundant quantities within the cytoplasm of the packaging cells.
To demonstrate the selectivity of Pestivirus genome encapsidation we chose to exploit an alphavirus replicon system due to the
similarities between Togaviruses and Flaviviruses in terms of RNA
replication and assembly (Strauss and Strauss, 1994). We used a
Semliki Forest virus (SFV) alphavirus replicon (SFV3-lacZ, Invitrogen, Carlsbad, CA) that accumulates to high levels in electroporated
cells (Liljestrom and Garoff, 1991). This replicon encodes the SFV NS
polyprotein from the genomic promoter, as well as the Escherichia
coli β-galactosidase (β-gal) reporter protein from a subgenomic promoter (Liljestrom and Garoff, 1991). Preliminary studies showed
that a SFV replicon replicated efficiently in several bovine cells after
electroporation (data not shown). The SFV3-lacZ RNA transcripts

Figure 3. Requirement of different sets of BVDV NS proteins to package rp7-NS5B and rNS3-5B replicons. NCL1 cells were infected with different recombinant vaccinia virus 36 h after being electroporated with replicons (A) rp7-NS5B or (B) rNS3-5B. The trans-packaged replicon pseudoparticles from RNA electroporated cells were filtered and applied to naive cells. Luciferase activities were measured 48 h after electroporation or
infection of replicons.
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electroporated into bovine cells and infected with helper vT7-ncpNADLgdd or BVDV-2 directed the expression of high levels of β-galactosidase in the packaging cells (Figure 2D, panel a). However, no
β-galactosidase could be detected in the indicator cells inoculated
with the cell culture filtrates from RNA electroporated cells (Figure
2D, panel b). These results indicated that the pestivirus packaging
machinery has a strong selection for the RNA genome, although the
packaging signals at the RNA level have not yet been defined.
Segregation of BVDV polyprotein expression between NS3 and NS4A
leads to the failure of virion packaging
The results presented above validated the use of the recombinant
vaccinia helper system to encapsidate and transduce BVDV replicons. Previous studies had indicated that NS2, NS3, NS4A and NS5B
played a role in the assembly of infectious virions (Agapov et al.,
2004; Ansari et al., 2004). To determine the minimum complement
of viral proteins required in trans to package the rp7-NS5B RNA (expressing all the NS proteins) into infectious particles, we engineered
a vaccinia virus vT7-E2 which expresses the BVDV structural proteins, C, Erns, E1 and E2, with the autoprotease, Npro, at the N-terminus of C to conserve the normal biogenesis of its N-terminus (Figure
2A). The Npro is neither a component of virions, nor is it required
for pestivirus virion assembly (Lai et al., 1999). Preliminary studies
showed that vaccinia recombinants expressed and processed both
E2 and NS2-3/NS3 as expected, due to the presence of signal sequences and the Jiv90 element, respectively (Lackner et al., 2006).
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Our results indicate that vT7-E2 helper transduced replicon
rp7-NS5B (luciferase) to target cells (Figure 3A). However, the efficiency of this process was significantly lower compared to that of
the vT7-ncpNADLgdd or vT7-cpNADLgdd helper packaged, suggesting that some of the BVDV NS proteins contributed to efficient
virion assembly. Therefore, we constructed and evaluated another
vaccinia BVDV recombinant that expressed the structural proteins
and p7 (vT7-p7). This helper vaccinia-BVDV recombinant yielded
equivalent trans-packaging efficiency as the complete polyprotein
from vT7-ncpNADLgdd or vT7-cpNADLgdd (Figure 3A). These results indicated that only the structural proteins are required in trans
to package cognate replicons expressing all the NS proteins. The efficiency of the process is greatly enhanced by the addition of p7 to
the polyprotein that gives rise to the structural proteins, suggesting a possible interaction between E2 and p7 (role for the precursor
E2-p7) in replicon packaging, and by extension, in the assembly of
progeny virions during BVDV infections.
In contrast with the rp7-NS5B replicon, the rNS3-5B failed to be
packaged by the structural proteins expressed under identical conditions (Figure 3B). Furthermore, rNS3-5B failed to be packaged by
helper expression of additional NS proteins, p7 and NS2-NS3 (Figure
3B). The functionality of the complementing vT7-ncpNS2-3 recombinant vaccinia was demonstrated by packaging of the rp7-NS5B,
suggesting that failure to package is not due to undetected mutations within structural genes. Furthermore, a different version of recombinant vaccinia virus, vT7-cpNS3, expressing polyprotein NproNS3 derived from cp-BVDV strain NADL, also failed to package

Figure 4. Characterization of recombinant vaccinia viruses expressing truncated ncp-BVDV polyproteins and its utilization for packaging of rNS35B and rp7-NS5B replicons. (A) Schematic representation of recombinant vaccinia virus genome expressing ncp-BVDV polyproteins. The thymidine kinase (TK) gene of vaccinia virus WR was replaced with different sizes of truncated BVDV polyprotein, respectively. T7 = T7 promoter,
R = Ribozyme of hepatitis D virus. (B) NS4A amino acid sequences included in vaccinia virus vT7-NS4A, vT7-NS4AM (retained middle domain
but deleted C-terminal) and vT7-NS4AN (retained only N-terminal). (C) The expression and processing of NS3 in cells infected with these recombinant vaccinia viruses. Cell lysate corresponding to 2 × 104 NCL1 cells were loaded in each lane of 8% SDS-PAGE and detection of NS3
was performed by western blotting using a primary monoclonal antibody against NS3. Note NS4AN was not processed from NS2-3 in the vT7ncpNS4AN vaccinia construct.
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and processed E2 and NS2-3 proteins correctly (Figure 4C, lanes 4, 5,
6). Recombinants vT7-NS4B, vT7-NS5A and vT7-NS4A packaged the
rNS3-5B replicon with equivalent efficiency to that of rp7-NS5B, respectively (Figs. 5A, B). These results indicate that all of the proteins
upstream of, and including NS4A could be provided in trans for efficient virion packaging. However, we have demonstrated that rNS35B could not be efficiently trans-packaged by recombinant vaccinia virus expressing polyprotein Npro-NS3. The packaging efficiency of the
rNS3-5B replicon by complementation with vT7-NS4A was comparable with vT7-NS4B, vT7-NS5A and vT7-Ngdd (Figs. 5A, B). These results suggest that the sequence context downstream of NS4A is not
essential for NS2-3-4A processing or complex formation. However,
we could not exclude the possibility of involvement of the polyprotein, NS4B-5B region, in virion packaging (Ansari et al., 2004).
The C-tail of NS4A is indispensable for efficient virion packaging

Figure 5. Mapping of minimum sets of nonstructural polyproteins required for trans-packaging of rNS3-5B. NCL1 cells were infected with
different recombinant vaccinia viruses 36 h after being electroporated with replicon rNS3-5B or rp7-NS5B. The trans-packaged replicon
pseudo-particles from the packaging cells were filtered and passed to
naive cells. Luciferase activities in packaging cells and indicator cells
were measured 48 h after electroporation or infection of replicons.
White bars represent replicon rNS3-5B, while gray bars represent replicon rp7-NS5B. (A) Mapping of the nonstructural polyproteins required for trans-packaging of rNS3-5B and rp7-NS5B replicon using
vT7-ncpNS4B, vT7-ncpNS5A and vT7-ncpNS5B in trans. (B) Mapping of the nonstructural polyproteins required for trans-packaging of
rNS3-5B and rp7-NS5B replicon using vT7-ncpNS2-3, vT7-ncpNS4AN,
vT7-ncpNS4AM and vT7-ncpNS4A in trans.

rNS3-5B (data not shown). Taken together, these results suggest that
the polyprotein downstream of NS3 is involved in efficient packaging of rNS3-5B.
It was surprising that vT7-cpNS3 could not trans-complement
rNS3-5B for packaging. It is worth noting that the cells harboring
the rNS3-5B replicon, expressed precursor NS3-NS4A-NS4B-NS5ANS5B that could be processed into functionally mature proteins.
Similarly, recombinant vaccinia virus, vT7-cpNS3, expressed precursor Npro-Erns-E1-E2-p7-NS2-3 that could be processed by host cellular signal peptidase. The two precursors overlap in the NS3 region, therefore, the cells harboring both rNS3-5B and vT7-cpNS3
expressed two truncated polyproteins that covered the entire BVDV
genome. We demonstrated that efficient trans-packaging of rNS3-5B
could be achieved by co-infection with recombinant vaccinia virus
vT7NADLgdd, which expresses the entire BVDV polyprotein with
the GDD motif in NS5B mutated to null the replication activity (Figure 3B). Thus, the failure of rNS3-5B to be packaged by vT7-cpNS3
indicated that contiguous expression of nonstructural proteins NS23 with its downstream polyproteins is essential for the efficient incorporation of rNS3-5B into functional virus particles.
Contiguous expression of NS2-3-4A is essential for efficient virion
packaging
To identify the critical NS proteins responsible for the failure to
incorporate rNS3-5B genomes into virion particles, we analyzed
their packaging using a recombinant vaccinia virus that expressed
the structural proteins with the NS protein segment, p7-NS4A or p7NS5A, as a single polyprotein derived from ncp-BVDV (Figure 4A).
Western blotting showed that all the vaccinia recombinants expressed

The most significant role of NS4A is to function as a cofactor in the
NS3-mediated cleavage of the viral polyproteins (Tautz et al., 2000;
Xu et al., 1997). Because the central domain of NS4A is critical for
this function, we engineered a C-terminal deletion NS4A mutant,
vT7-NS4AM, and another mutant lacking both the C-terminal domain and the middle domain of NS4A, vT7-NS4AN. The hydrophobic N-terminus of NS4A is predicted to adopt a helix conformation,
which is likely to insert itself into membranes (Figure 4B). Western
blotting results showed that NS2-3 was processed efficiently from its
NS4AM precursor (Figure 4C, lane 3). It is important to note that the
NS2-3-4AN precursor expressed from vT7-NS4AN was larger than
the normal NS2-3 molecule by
2.2 kDa, indicating that the N-terminal domain of NS4A molecule was retained with NS2-3 precursor
(Figure 4C, lane 2). Both replicons, rNS3-5B and rp7-NS5B, were efficiently packaged by the recombinant vaccinia virus, vT7-ncpNS4A
(Figure 5B). However, none of the vaccinia virus recombinant NS4A
deletion mutants, vT7-NS4AN and vT7-NS4AM, were able to complement packaging of the rNS3-5B replicon (Fig 5B). A summary of
the packaging of the two replicons with different recombinant vaccinia virus mutants is given in Table 1. These findings suggest that
the C-tail of NS4A is indispensable for efficient virion packaging.
The close link between BVDV virion packaging and replication machinery
Our results correlate with recent findings on the involvement of
several NS proteins in the packaging of genomes generated by an active viral replicase complex (Agapov et al., 2004; Ansari et al., 2004).
Furthermore, Agapov et al., 2004 demonstrated the importance of
the NS2-3 precursor in the production of infectious virions, although
NS2 was dispensable for genome replication (Agapov et al., 2004).
Taken together with the results presented above, the role of NS2
and NS2-3 precursors may involve the engagement of the replicase
Table 1. Summary of BVDV replicon trans-packaging results with different recombinant vaccinia viruses expressing different lengths of
BVDV polyproteins.

vT7-E2
vT7-p7
vT7-ncpNS2-3
vT7-ncpNS4AN
vT7-ncpNS4AM
vT7-ncpNS4A
vT7-ncpNS4B
vT7-ncpNS5A
vT7-ncpNgdd
vT7-cpNgdd

rp7-NS5B

rNS3-5B

+
+
+
+
+
+
+
+
+
+

−
−
−
−
−
+
+
+
+
+

Replicon rp7-NS5B contains BVDV polyprotein from p7 to NS5B,
while rNS3-5B contains polyprotein from NS3 to NS5B. Recombinant
vaccinia viruses express BVDV polyproteins from Npro to E2, p7, NS3,
NS4A N-terminus, NS4A middle domain, NS4B, NS5A, NS5B, respectively. +: packageable; −: unpackageable.
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complex by the structural proteins. To examine the recognition of
the replication machinery by the structural proteins, we analyzed the
production and release of virions by recombinant vaccinia virus carrying the WT BVDV genome and the BVDV genome having an inactive NS5B. Cells were infected with these recombinant vaccinia viruses and culture supernatants collected at 16 h post-infection. Total
cell lysates and culture supernatants were analyzed by western blot
analysis to assess the levels of BVDV E2 protein expression in infected
cells and supernatant which will indicate the virion released into the
media. Fractions that co-sedimented with standard BVDV infectious
virions (density 1.12 to 1.14) were found to contain detectable E2 (Figure 6, lane 6) and to be infectious to bovine cells (data not shown).
The relative amounts of E2 present in the culture supernatant of
cells infected with vaccinia virus recombinants expressing wt NS5B or
the catalytically inactive NS5Bgdd were determined by densitometry
and normalized by the relative amounts of total E2 expressed in the
infected cells. Vaccinia-derived BVDV genomes with inactive NS5B
but otherwise normal polyprotein, released only 20% of the virions
compared to the cells infected with vT7-cpNADL (Fig 6, lanes 5 and
6). Furthermore, the virion produced by vT7-cpNgdd were noninfectious in bovine cells (data not shown). On the other hand the amount
of expressed E2 in vT7-Ngdd infected cells (lane 2) was slightly
greater than the vT7-cpNADL (lane 3). This difference may be due to
the fact that in vT7-cpNADL infected cells, part of the E2 is used for
authentic virion production, while in vT7-cpNgdd infected cells most
of the E2 is retained inside the cells. It was also evident that viral genome replication in vT7-cpNADL infection did not lead to increased
production of E2 inside the cells (lane 3) as compared to vT7-cpNgdd
(lane 2) due to the production of high levels of transcripts generated
by vaccinia infection. Hence, the expressed protein from viral replication is masked by expression products derived from vaccinia transcripts. These results strongly suggest that active genome replication

Figure 6. Lack of genome replication is correlated with reduced efficiency of virion assembly and release. RK-13 cells were infected
with both T7 helper vaccinia virus vTF7-3 and vT7-cpNADL or vT7cpNgdd, respectively. The supernatant which contains both rVV and
BVDV virions was filtered through 0.1 mm filter and centrifuged to
pellet the virions. The infected cell lysates and virion pellets were resolved on 8% SDS-PAGE and western blot analysis was performed using a monoclonal antibody against BVDV E2. Lanes 1–3 represent cell
lysates from the infected cells with vTF7-3, vTF7-3 + vT7-cpNgdd and
vTF7-3 + vT7-cpNADL, respectively, while lanes 4–6 indicate the supernatant from their corresponding infected cells.
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enhances the production and/or release of virions and are also
consistent with the previous report where involvement of the
NS5B in genome packaging is demonstrated (Ansari et al., 2004).
Discussion
We have developed an efficient BVDV reporter replicon packaging system, in which both the minimum replicon, rNS3-5B, and the
long replicon, rp7-NS5B, replicated and assembled with comparable
efficiency. We employed a recombinant vaccinia virus system to express the BVDV packaging proteins rather than a BVDV helper virus
or dual replicon approach (Agapov et al., 2004). The pure progeny
BVDV virions can be easily separated from recombinant vaccinia virions by filtration. The efficiency of the trans-packaging system using recombinant vaccinia virus expressing polyprotein from Npro to
NS4A is comparable to that using a helper BVDV virus, which occurs in nature. Furthermore, the introduction of recombinant vaccinia virus during the late stages of BVDV replicon replication minimizes viral recombination opportunity. Our unpublished data has
shown that a chimeric BVDV genome up to 15 kb in length could
be efficiently assembled into infectious virions. Therefore, the relatively large cloning capacity of the replicons accommodates different purposes. The desired heterologous genes could be effectively
cloned into the firefly luciferase or neomycin phosphotransferase
gene position. Thus, this replicon trans-packaging system can serve
as a gene delivery system at the cellular or animal level.
Consistent with our results, Agapov et al. (2004) reported that uncleaved NS2-3 was required for the production of infectious BVDV.
Both, the system used by Agapov et al. (2004) and our system demonstrated the importance of the expression of NS4A in cis with NS23 protein. In contrast to our results, Agapov et al. (2004) determined
that the expression of NS4A in cis with NS2-3 was not essential for,
but markedly increased the packaging efficiency. This difference
may be due to the different packaging systems used in the studies. Agapov et al. (2004) used a second BVDV replicon to express the
functional NS2-3-4A in trans, while we used a recombinant vaccinia
virus to express the functional NS2-3-4A in trans. This may result in
different protein localization and different packaging efficiencies.
High levels of NS3 are expressed by cp-BVDV which is well correlated with an enhanced accumulation of intracellular viral RNA
as compared to ncp-BVDV strains (Lackner et al., 2004). However,
virion production from cp-BVDV is not significantly different than
that from ncp-BVDV in tissue culture. This indicated that a greater
level of viral genome and packaging proteins were not enough for
increased virion production. It has been demonstrated that NS2-3
was involved in virion assembly. However, it was surprising that
expression of NS2-3-4A, but not NS2-3, could complement replicon
assembly in our packaging system, suggesting that the NS2-3-4A
precursor was involved in virion assembly. We also observed that
extending NS2-3-4A to NS2-3-4A-NS4B or NS2-3-4A-NS4B-NS5A
did not increase the packaging efficiency of rNS3-5B. This demonstrated that the region downstream of NS4A could be separated
from NS2-3-4A for assembly function.
Thus, the contiguous expression of Npro-Erns-E1-E2-p7-NS2-3
with NS4A contributes to the successful trans-packaging of rNS35B. A previous report suggested that p7 could be separated from E2
and NS2 with efficient virion packaging (Harada et al., 2000). Therefore, our results indicate that the contiguous expression of NS2-34A is essential for efficient trans-packaging of rNS3-5B. Based on the
information that NS3 cannot be functionally replaced by uncleaved
NS2-3, as well as, the strict correlation between NS3 level and efficiency of RNA replication (Lackner et al., 2004), this strongly suggested that NS3, but not NS2-3, is an essential component of the viral replication complex. Thus, we propose that precursor NS2-3-4A,
provided by the recombinant vaccinia viruses, was involved in efficient virion trans-packaging but not virus replication.
Having shown the importance of the NS2-3-4A precursor protein,
we suggest that cp-BVDV also employs this precursor for the virion
assembly function. Thus, pestiviruses exploit polyprotein precursors
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for different viral functions. The temporal regulation of NS2-3-4A autoprocessing is likely necessary for the switch between the phases of
highly active viral RNA replication and virus morphogenesis. The
processing speed, order and ratio of the polyprotein precursor may
regulate different stages of the BVDV life cycle, i.e. translation, replication and assembly. Although we did not provide evidence for a direct role of the NS proteins in the recruitment of actively replicating
genomic RNA to assembly sites, the involvement of the NS proteins
in virion assembly provides an obvious candidate.
Materials and methods
Viruses, cells and reagents
Rabbit kidney (RK13, CCL-37), monkey kidney (CV1, CCL-70),
and thymidine kinase-deficient human osteosarcoma (TK-143B,
CRL-8303) cells were obtained from the American Type Culture
Collection (Manassas, VA). Bovine uterine cells (NCL1) and monoclonal antibodies against BVDV proteins were gifts from Dr. Edward Dubovi (Cornell University, Ithaca, NY). BVDV genotype 1
(BVDV-1) isolate NADL (cytopathogenic) and vaccinia virus strain
WR were obtained from the American Type Culture Collection.
BVDV genotype 2 (BVDV-2) isolate 890 was a gift from Dr. Julia
Ridpath (USDA, Ames, IA). Recombinant vaccinia virus producing the T7 RNA polymerase (vTF7-3) was a gift from Dr. Bernard
Moss (NIH, Bethesda, MD). DNA restriction/modification enzymes and luciferase assay systems were purchased from Promega
(Madison, WI). Fetal bovine serum (FBS), γ-irradiated FBS (γ-FBS),
equine serum, antibiotics for tissue culture (penicillin and streptomycin premix), minimum essential medium (MEM), Dulbecco’s
MEM (DMEM) and oligonucleotides were purchased from Invitrogen (Carlsbad, CA). The NCL1 cells were grown in MEM supplemented with penicillin–streptomycin and 10% equine serum, while
CV1 and TK-143B cells were grown in DMEM supplemented with
penicillin and 10% FBS. All cells were maintained at 37 °C with 5%
CO2. Plasmids encoding the full-length BVDV NADL genome and
its derivatives lacking the Jiv cellular insert that mediates cytopathogenicity (Rinck et al., 2001) were described previously (Vassilev et al., 1997). A plasmid that allows transcription of RNA molecules encoding Renilla luciferase with expression driven by the
encephalomyocarditis virus (EMCV) IRES was described previously (Ansari et al., 2004).
Construction of bicistronic subgenomic BVDV reporter replicons
Bicistronic reporter replicons, rNS3-5B and rNS3-5Bgdd, were
derived from the pNADLp15 full-length infectious genome of the
BVDV strain NADL described previously (Ansari et al., 2004; Vassilev et al., 1997). Compared to rNS3-5B, rNS3-5Bgdd has a disabled
NS5B by virtue of replacing the conserved GDD motif (amino acid
residues 447 to 449, using NS5B numbering) with ATR (Ansari et al.,
2004). Another replicon, rp7-NS5B, was constructed as described for
rNS3-5B, with the EMCV IRES inserted upstream of p7 rather than
NS3. The junction between Npro and p7 consisted of a stretch of nucleotides encoding for short amino acid segments of the N- and Ctermini of capsid (C) protein, to mediate the correct membrane targeting of p7 and its subsequent processing. To this end, the central
domain of the capsid (nucleotides 909–1079, encoding amino acids
175–232 of the wt virus polyprotein) (Genbank accession AJ133738)
was deleted by overlap extension PCR.
Construction of recombinant vaccinia viruses expressing BVDV viral
proteins
Construction of recombinant vaccinia viruses by homologous recombination between a transfer plasmid carrying BVDV sequences
and the vaccinia virus WR genome was performed as previously described (Ausubel et al., 1989). The cloning sites in the vaccinia trans-
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fer plasmid were flanked by the vaccinia virus DNA sequences, TKL
(left) and TKR (right). Different sizes of the BVDV truncated polyproteins were first cloned into the vaccinia transfer vector, pSC59
(Ausubel et al., 1989). The transfer vectors were engineered to contain a T7 promoter with a transcription start site at nucleotide 1 of
the BVDV genome that contained either full-length BVDV genome
cDNA or deletions in the 3′ end of the open reading frame to generate C-terminal truncated BVDV polyproteins. All constructs contained an intact BVDV 3′ UTR immediately followed by the hepatitis
D virus ribozyme to yield a genuine BVDV 3′ end.
Vaccinia recombinants were generated in CV1 cells by transfecting with the transfer plasmid DNA followed by infection with
vaccinia virus WR. Selection of recombinant vaccinia viruses lacking functional TK was performed by passage in TK−143B cells in the
presence of 5-bromodeoxyuridine (BrdU). Candidate recombinant
viruses were co-infected with vTF7-3 helper virus followed by the
detection of BVDV E2 protein expression in infected CV1 cells using indirect immunofluorescence microscopy and a specific mouse
monoclonal antibody against E2. The plaques expressing BVDV E2
were purified three times and the expression and proper processing
of all the structural and NS proteins was confirmed by western blotting. The resulting recombinant vaccinia viruses (rVV) were termed
vT7-cpNADL, which expresses the full-length BVDV genomic RNA
(from the cpNADL strain) and vT7-cpNgdd, which expresses the
full-length BVDV genomic RNA of cpNADL with the GDD motif
of NS5B mutated to ATR. Analogous vaccinia virus recombinants,
termed vT7-ncpNADL and vT7-ncpNgdd encode BVDV genomes
that differ from the previous ones in their NS2 protein lacking the
insert of bovine origin. Additional rVV were generated to express
truncated versions of the BVDV polyprotein namely: vT7-E2, vT7p7, vT7-ncpNS2-3, vT7-ncpNS4AN, vT7-ncpNS4AM, vT7-ncpNS4A,
vT7-ncpNS4B, and vT7-ncpNS5A. These viruses express the ncpBVDV NADL strain polyprotein spanning from Npro to E2, p7, NS3,
NS4A N-terminus, NS4A middle domain, NS4A, NS4B and NS5A,
respectively.
In vitro RNA transcription and electroporation
DNA templates for in vitro transcription were produced by PCR
amplification of the region containing the T7 promoter and the entire replicon of the relevant plasmids using Klentaq polymerase
(Clontech BD Biosciences, Palo Alto, CA). In vitro RNA transcription was performed using the T7-MEGAscript kit (Ambion, Austin,
TX) as described previously (Ansari et al., 2004). The pIRES-Renilla
plasmid was linearized with XbaI enzyme and used for RNA transcription as described previously (Ansari et al., 2004). At all times
the electroporation efficiency of the replicon RNA was monitored
by co-electroporation of a reporter RNA encoding Renilla luciferase in which the expression was driven by the EMCV IRES. Corrections for electroporation efficiency were not necessary due to the repeatedly consistent levels of Renilla luciferase expression (105 RLU)
in each experiment.
RNA transcripts from a Semliki Forest Virus replicon, encoding β-galactosidase (pSFV3-LacZ) (Invitrogen, Carlsbad, CA), were
prepared using plasmid DNA linearized with SpeI. Capped RNA
transcripts were synthesized in vitro with SP6-polymerase in the
presence of m7G(5′)ppp(5′)G cap analog by using the mMessage
mMachine kit (Ambion, Austin, TX). RNA concentration following
transcription reactions was determined fluorometrically using Ribogreen (Molecular Probes, Eugene, OR). An aliquot of the transcription reaction was analyzed by formaldehyde agarose gel electrophoresis to determine the integrity of the transcripts. Transcription
reactions were stored at − 80 °C in small aliquots for electroporation
purposes.
NCL1 cells (70 to 80% confluent) were trypsinized, washed two
times with ice-cold DMEM and resuspended at a concentration of
2 × 107 cells/ml in cytomix as described previously (Ansari et al.,
2004). Briefly, transcripts (2 μg) were electroporated into 2 × 106
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NCL1 cells in a 100 μl volume using a 0.2 cm gap cuvette with a single electrical pulse discharge of 235 V, 100 μF and 48 Ohms. Replication of the electroporated RNA was quantified by northern blot
analysis of cells harvested at various times post-electroporation as
described previously (Ansari et al., 2004). Electroporation experiments were repeated a minimum of three times, starting from independent in vitro RNA synthesis reactions.
Reporter assays
Firefly and Renilla Luciferase assays were performed using the
Dual Luciferase Assay system (Promega, Madison, WI) following
the manufacturer’s protocol. Briefly, the NCL1 cells were harvested
and lysed in lysis buffer. An equivalent of 1 × 105 cells was used for
the measurement of luciferase enzyme activity. Light emission was
measured using a TopCount Luminescence Counter (Packard Instruments, Meriden, CT). To detect expression of β-galactosidase in
transfected cells, monolayers were fixed with 0.2% paraformaldehyde in PBS for 5 min at room temperature. After 3 washes in PBS,
the cells were incubated in a chromogenic substrate solution containing 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-13-d-galactopyranoside), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 2 mM MgCl2 in PBS. The appearance of blue color in the
cell monolayers was monitored following incubation at 37 °C. Images were captured using wide-field digital photomicroscopy at 6hour intervals for a period of 24 h.
Infections with recombinant vaccinia viruses, BVDV or packaged replicons
Bovine cell monolayers were rinsed with PBS and inoculated
with cell culture fluids containing vaccinia recombinants, BVDV
or packaged replicon virions in a volume sufficient to cover the entire cell monolayer. After adsorption for 1 h at 37 °C the supernatant was removed, monolayer rinsed and supplemented with prewarmed complete media and incubated in a 37 °C incubator until
further analysis.
Western blotting
NCL1 cells (~ 80% confluency) were infected with each recombinant vaccinia virus (multiplicity of infection, MOI = 5) together with
T7 helper vaccinia virus (MOI = 3) to achieve a greater level of expression. Total cell lysates were collected 12 h after vaccinia infection while ncp-BVDV or cp-BVDV-infected cells were harvested at
24 h post-infection. Cell lysate, the equivalent of ~ 2 × 104 cells, was
loaded into each well of an 8% SDS-PAGE gel. Proteins were separated and electrotransferred to nitrocellulose membranes (HybondC, Amersham, Arlington Heights, IL). Proteins were detected using
monoclonal antibodies against E2 (Antibody #4b6) or NS3. Antibody binding was detected using a chemiluminescent assay as described before (Ansari et al., 2004).
Trans-packaging of BVDV replicons following infection with either
recombinant vaccinia viruses expressing BVDV proteins or with BVDV-2
Approximately 2 μg of replicon RNA transcript and 0.4 μg of Renilla reporter RNA were mixed and electroporated into 2 × 106 NCL1
cells. Aliquots of the transfected cells, termed the packaging cells,
were evenly distributed into ten fractions and plated in a 12-wellplate. One well was harvested for luciferase activity at 48 h postelectroporation to quantify the levels of packageable replicon RNA
in the electroporated cells. The remaining nine wells were used for
infection with recombinant vaccinia viruses expressing BVDV proteins or with BVDV-2 at 36 h post-electroporation. A system that
employs a dual vaccinia T7 promoter–T7 RNA polymerase co-infection was used to express BVDV RNA (Fuerst et al., 1987). To this
end, cells previously electroporated with replicon RNA were co-infected with the recombinant vaccinia viruses expressing BVDV under T7 promoter control (MOI = 5) and vTF7-3 recombinant vac-
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cinia virus constitutively expressing T7 RNA polymerase (MOI = 1).
The cells were incubated for an additional 24 h after which the medium containing packaged replicons was harvested, passed through
a 0.1 μm filter, reducing the helper vaccinia virus titer to undetectable levels and stored at 4 °C for further use. To assess the presence
of packaged replicons, the culture filtrates (0.5 ml) were used to inoculate fresh NCL1 cells in duplicate (termed indicator cells) in 12well plates. The indicator cells were cultured for 48 h and harvested
to measure luciferase activity as a reporter of the number of packaged replicons delivered to the indicator cells by functional virions.
Virion release from cells infected with recombinant vaccinia virus expressing wt or replication-incompetent BVDV genome
The RK-13 rabbit kidney cells (~ 5 × 105) were co-infected with
vTF7-3 (MOI = 3) and vT7-cpNADL or vT7-cpNgdd (MOI = 5), for
1 h at 37 °C. The infected cells were rinsed with PBS and cultured
in DMEM containing 2.5% γ-irradiated FBS for an additional 22 h.
To investigate the presence of released BVDV virions, culture fluids
were collected and centrifuged at 13,000 g for 15 min at 4 °C to remove cell debris and the supernatant filtered through a 0.1 mm filter to remove the vaccinia virions. The filtrate was then centrifuged
using a 10% sucrose cushion and the fraction containing BVDV virions (density of 1.12 to 1.14) was collected and analyzed by western
blotting as described above. The infected cell monolayer was harvested in SDS-PAGE sample buffer for subsequent analysis by western blotting to determine the relative structural protein expression
levels in the different samples.
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